These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2505187)

  • 1. Carnitine and weakness in haemodialysis patients.
    Rogerson ME; Rylance PB; Wilson R; De Sousa C; Lanigan C; Rose PE; Howard J; Parsons V
    Nephrol Dial Transplant; 1989; 4(5):366-71. PubMed ID: 2505187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.
    Sakurauchi Y; Matsumoto Y; Shinzato T; Takai I; Nakamura Y; Sato M; Nakai S; Miwa M; Morita H; Miwa T; Amano I; Maeda K
    Am J Kidney Dis; 1998 Aug; 32(2):258-64. PubMed ID: 9708610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary L-carnitine deficiency in chronic hemodialysis patients].
    Achenbach H; Würzberger G; Seim H; Löster H; Strauss B
    Z Gesamte Inn Med; 1989 Jan; 44(1):18-22. PubMed ID: 2711712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle carnitine deficiency in old age. Case report and therapeutic results.
    Martin JJ; Vercruyssen A; de Barsy T; Ceuterick C
    Clin Neurol Neurosurg; 1985; 87(4):275-81. PubMed ID: 4092408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine deficiency induced during intermittent haemodialysis for renal failure.
    Bohmer T; Bergrem H; Eiklid K
    Lancet; 1978 Jan; 1(8056):126-8. PubMed ID: 87556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Levels of L-carnitine in serum of patients with chronic renal failure treated by hemodialysis (HD)].
    Wanic-Kossowska M; Bombicki K; Kozioł L; Czarnecki R
    Pol Arch Med Wewn; 1998 Apr; 99(4):314-22. PubMed ID: 9760819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral L-carnitine on serum myoglobin in hemodialysis patients.
    Feinfeld DA; Kurian P; Cheng JT; Dilimetin G; Arriola MR; Ward L; Manis T; Carvounis CP
    Ren Fail; 1996 Jan; 18(1):91-6. PubMed ID: 8820505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carnitine administration in patients with chronic renal failure undergoing periodic dialysis, evaluated by computerized electromyography.
    Rocchi L; Feola I; Calvani M; D'Iddio S; Alfarone C; Frascarelli M
    Drugs Exp Clin Res; 1986; 12(8):707-11. PubMed ID: 3757765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominantly inherited megalencephaly, muscle weakness, and myoliposis: a carnitine-deficient myopathy within the spectrum of the Ruvalcaba-Myhre-Smith syndrome.
    Powell BR; Budden SS; Buist NR
    J Pediatr; 1993 Jul; 123(1):70-5. PubMed ID: 8320628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialysis-related carnitine disorder.
    Hedayati SS
    Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacokinetic model for L-carnitine in patients receiving haemodialysis.
    Fornasini G; Upton RN; Evans AM
    Br J Clin Pharmacol; 2007 Sep; 64(3):335-45. PubMed ID: 17506778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effect of intravenous L-carnitine therapy on function, structure and fatty acid metabolism of skeletal muscle in patients receiving chronic hemodialysis.
    Siami G; Clinton ME; Mrak R; Griffis J; Stone W
    Nephron; 1991; 57(3):306-13. PubMed ID: 2017271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and muscle carnitine levels in haemodialysis patients with morphological-ultrastructural examination of muscle samples.
    Savica V; Bellinghieri G; Di Stefano C; Corvaja E; Consolo F; Corsi M; Maccari F; Spagnoli LG; Villaschi S; Palmieri G
    Nephron; 1983; 35(4):232-6. PubMed ID: 6646296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine metabolism in uremia.
    Guarnieri G; Situlin R; Biolo G
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S63-7. PubMed ID: 11576925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Muscle carnitine deficiency: report of 8 cases with clinical, electromyographic, histochemical and biochemical studies].
    Werneck LC; Di Mauro S
    Arq Neuropsiquiatr; 1985 Sep; 43(3):281-95. PubMed ID: 4091739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral carnitine supplementation for dyslipidemia in chronic hemodialysis patients.
    Naini AE; Sadeghi M; Mortazavi M; Moghadasi M; Harandi AA
    Saudi J Kidney Dis Transpl; 2012 May; 23(3):484-8. PubMed ID: 22569432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy.
    Campos Y; Huertas R; Lorenzo G; Bautista J; Gutiérrez E; Aparicio M; Alesso L; Arenas J
    Muscle Nerve; 1993 Feb; 16(2):150-3. PubMed ID: 8429838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine palmityltransferase deficiency with permanent weakness.
    Gieron MA; Korthals JK
    Pediatr Neurol; 1987; 3(1):51-3. PubMed ID: 3508048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levels of carnitine and homocysteine in plasma of long-term hemodialysis patients with chronic renal failure].
    Kokot F; Chudek J; Łysiak-SzydŁowska W; Domagała B; Adamczak M; Ignacy W; Kania M; Rutkowski B; Szczeklik A; Wiecek A
    Pol Arch Med Wewn; 2001 Dec; 106(6):1131-6. PubMed ID: 12026532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma carnitine deficiency. Clinical observations in 51 pediatric patients.
    Winter SC; Szabo-Aczel S; Curry CJ; Hutchinson HT; Hogue R; Shug A
    Am J Dis Child; 1987 Jun; 141(6):660-5. PubMed ID: 3578191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.